Annual EBITDA
$167.85M$57.90M+52.67%
Summary
- Current Value
- As of today, KRYS annual EBITDA is $167.85M, up +52.67% on
- Historical Performance
- KRYS annual EBITDA is up +244.52% over the past 3 years, up +638.87% over the past 5 years
- All-Time High Comparison
- KRYS annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- KRYS annual EBITDA is +244.52% above its 3-year low of -$116.14M reached on an earlier date
- Sector Comparison
- KRYS annual EBITDA is higher than 85.59% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $167.85M | +52.7% | +244.5% | +638.9% | +10000.0% | |
| Quarterly EBITDA | $59.98M | +46.8% | +262.8% | +481.4% | +100.0% | |
| TTM EBITDA | $204.41M | +29.3% | +250.1% | +519.3% | +100.0% | |
| Price | $348.09 | +146.5% | +180.6% | +492.9% | – | |
| PE Ratio | 43.62 | +51.8% | – | – | – | |
| Annual Revenue | $389.13M | +33.9% | +100.0% | +100.0% | +100.0% | |
| Annual EPS | $6.84 | +128.1% | +224.6% | +499.4% | +6189.9% | |
| $161.30M | +56.3% | +234.2% | +588.8% | +10000.0% | ||
| Annual Net Income | $204.83M | +129.7% | +246.3% | +736.8% | +10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $167.85M | at high | |
| 5Y | $167.85M | at high | |
| All | $167.85M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$116.14M | N/A | +244.5% |
| 5Y | -$116.14M | +244.5% | |
| All | -$116.14M | +244.5% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $167.85M | +52.7% | |
| $109.94M | +219.2% | |
| -$92.22M | +20.6% | |
| -$116.14M | -77.3% | |
| -$65.51M | -110.3% |
| Year | Value | Change |
|---|---|---|
| -$31.15M | -47.6% | |
| -$21.11M | -79.3% | |
| -$11.78M | -147.9% | |
| -$4.75M | -316.2% | |
| -$1.14M | - |
FAQ
- What is the current annual EBITDA of KRYS?
- As of today, KRYS annual EBITDA is $167.85M
- What is 1-year change in KRYS annual EBITDA?
- KRYS annual EBITDA is up +52.67% year-over-year
- What is 3-year change in KRYS annual EBITDA?
- KRYS annual EBITDA is up +244.52% over the past 3 years
- How far is KRYS annual EBITDA from its all-time high?
- KRYS annual EBITDA is currently at its all-time high
- How does KRYS annual EBITDA rank versus sector peers?
- KRYS annual EBITDA is higher than 85.59% of companies in Healthcare sector
- When is KRYS next annual earnings release?
- As of today, the next annual earnings release for KRYS has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$59.98M$4.57M+8.24%
Summary
- Current Value
- As of today, KRYS quarterly EBITDA is $59.98M, up +8.24% on
- Historical Performance
- KRYS quarterly EBITDA is up +46.84% year-over-year, up +262.78% over the past 3 years
- All-Time High Comparison
- KRYS quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- KRYS quarterly EBITDA is +262.78% above its 3-year low of -$36.85M reached on an earlier date
- Sector Comparison
- KRYS quarterly EBITDA is higher than 84.72% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $59.98M | +8.2% | +46.8% | +262.8% | +481.4% | |
| Annual EBITDA | $167.85M | – | +52.7% | +244.5% | +638.9% | |
| TTM EBITDA | $204.41M | +10.3% | +29.3% | +250.1% | +519.3% | |
| Price | $348.09 | +12.4% | +146.5% | +180.6% | +492.9% | |
| PE Ratio | 43.62 | +5.4% | +51.8% | – | – | |
| Quarterly Revenue | $119.22M | +2.5% | +24.1% | +100.0% | +100.0% | |
| Quarterly EPS | $1.79 | -2.6% | +38.6% | +243.4% | +342.4% | |
| $58.42M | +8.8% | +48.6% | +253.5% | +456.4% | ||
| Quarterly Net Income | $54.77M | -2.1% | +42.9% | +264.9% | +434.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $59.98M | at high | |
| 3Y | $59.98M | at high | |
| 5Y | $59.98M | at high | |
| All | $59.98M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $40.85M | N/A | +46.8% |
| 3Y | -$36.85M | N/A | +262.8% |
| 5Y | -$36.85M | +262.8% | |
| All | -$36.85M | +262.8% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of KRYS?
- As of today, KRYS quarterly EBITDA is $59.98M
- What is KRYS quarterly EBITDA most recent change?
- KRYS quarterly EBITDA was up +8.24% on June 30, 2026
- What is 1-year change in KRYS quarterly EBITDA?
- KRYS quarterly EBITDA is up +46.84% year-over-year
- How far is KRYS quarterly EBITDA from its all-time high?
- KRYS quarterly EBITDA is currently at its all-time high
- How does KRYS quarterly EBITDA rank versus sector peers?
- KRYS quarterly EBITDA is higher than 84.72% of companies in Healthcare sector
- When is KRYS next earnings release?
- The next earnings release for KRYS is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$204.41M$19.13M+10.33%
Summary
- Current Value
- As of today, KRYS TTM EBITDA is $204.41M, up +10.33% on
- Historical Performance
- KRYS TTM EBITDA is up +29.34% year-over-year, up +250.05% over the past 3 years
- All-Time High Comparison
- KRYS TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- KRYS TTM EBITDA is +250.05% above its 3-year low of -$136.23M reached on an earlier date
- Sector Comparison
- KRYS TTM EBITDA is higher than 85.39% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $204.41M | +10.3% | +29.3% | +250.1% | +519.3% | |
| Annual EBITDA | $167.85M | – | +52.7% | +244.5% | +638.9% | |
| Quarterly EBITDA | $59.98M | +8.2% | +46.8% | +262.8% | +481.4% | |
| Price | $348.09 | +12.4% | +146.5% | +180.6% | +492.9% | |
| PE Ratio | 43.62 | +5.4% | +51.8% | – | – | |
| TTM Revenue | $440.48M | +5.5% | +22.6% | +100.0% | +100.0% | |
| TTM EPS | $7.98 | +6.7% | +62.3% | +247.2% | +419.7% | |
| $197.75M | +10.7% | +30.3% | +240.7% | +488.9% | ||
| TTM Net Income | $241.47M | +7.3% | +64.6% | +272.0% | +562.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $204.41M | at high | |
| 3Y | $204.41M | at high | |
| 5Y | $204.41M | at high | |
| All | $204.41M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $158.05M | N/A | +29.3% |
| 3Y | -$136.23M | N/A | +250.1% |
| 5Y | -$136.23M | +250.1% | |
| All | -$136.23M | +250.1% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of KRYS?
- As of today, KRYS TTM EBITDA is $204.41M
- What is KRYS TTM EBITDA most recent change?
- KRYS TTM EBITDA was up +10.33% on June 30, 2026
- What is 1-year change in KRYS TTM EBITDA?
- KRYS TTM EBITDA is up +29.34% year-over-year
- How far is KRYS TTM EBITDA from its all-time high?
- KRYS TTM EBITDA is currently at its all-time high
- How does KRYS TTM EBITDA rank versus sector peers?
- KRYS TTM EBITDA is higher than 85.39% of companies in Healthcare sector
- When is KRYS next earnings release?
- The next earnings release for KRYS is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- KRYS Official Website www.krystalbio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1711279/000171127926000016/0001711279-26-000016-index.htm
- KRYS Profile on Yahoo Finance finance.yahoo.com/quote/KRYS
- KRYS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/krys